Stock Report

All about this stock under one free report Last Updated: 08-Oct-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Thyrocare Tech Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: THYROCARE | BSE: 539871

₹513.05

up-down-arrow ₹-16.75 (-3.16%)

As on 07-Oct-2026IST

Market cap

info icon

₹8,165 Cr

Revenue (TTM)

info icon

₹876 Cr

P/E Ratio

info icon

46.3

P/B Ratio

info icon

13

Div. Yield

info icon

2.7 %

Edit peer-selector-edit
Thyrocare Tech Global Health Dr. Lal Pathlabs Krishna Institute Vijaya Diagno
Market cap (₹ Cr)
 8,165 34,792 32,654 29,155 15,062
Revenue (₹ Cr)
 876 4,683 2,891 4,213 857
Net Profit (₹ Cr)
 174.04 552.34 546.30 190.80 187.49
Net Margin (%)
 19.50 11.55 18.23 4.49 21.32
RoE (%)
 32.40 14.93 23.03 9.45 20.58
Price to Earnings
 46.31 62.56 60.26 142.71 80.34
Price-To-Book
 12.97 8.46 12.50 7.71 14.95

Income Statement (₹ Cr)

Thyrocare Tech Global Health Dr. Lal Pathlabs Krishna Institute Vijaya Diagno
Operating Revenue arrow
876.03 4,683.37 2,890.80 4,212.50 857.13
Total Income arrow
892.52 4,783.78 2,995.90 4,248.00 879.41
Total Expenditure arrow
594.49 3,704.62 2,053.10 3,379.70 495.19
EBITDA arrow
281.54 978.75 837.70 832.80 361.94
Depreciation arrow
59.66 246.41 171.60 330.60 96.06
EBIT arrow
221.88 732.34 666.10 502.20 265.89
Interest arrow
3.37 92.01 24.40 253.30 36.75
Other Income arrow
16.49 100.41 105.10 35.50 22.28
Exceptional Items arrow
-6.16 -20.61 -30.10 -11.20 0.00
Profit before Tax arrow
228.84 720.14 716.70 273.20 251.42
Provision for Tax arrow
54.80 167.80 170.40 82.40 63.93
Profit after Tax arrow
174.04 552.34 546.30 190.80 187.49

Liabilities (₹ Cr)

Thyrocare Tech Global Health Dr. Lal Pathlabs Krishna Institute Vijaya Diagno
Shareholder's Funds arrow
585.50 3,961.57 2,508.20 2,247.40 957.15
Minority Interest arrow
0.41 3.84 -4.40 9.90 0.00
Non-Current Liabilities arrow
51.29 1,293.60 154.00 3,961.30 426.03
Current Liabilities arrow
109.91 627.13 450.70 1,238.90 123.87
Total Liabilities arrow
804.51 5,905.00 3,139.97 7,690.70 1,507.05

Assets (₹ Cr)

Thyrocare Tech Global Health Dr. Lal Pathlabs Krishna Institute Vijaya Diagno
Non-Current Assets arrow
300.64 3,128.95 1,176.30 5,416.90 737.24
Current Assets arrow
372.29 1,674.92 1,566.60 937.40 321.90
Total Assets arrow
804.51 5,905.00 3,139.97 7,690.70 1,507.05
Total Debt* arrow
0.00 631.08 0.00 3,244.00 0.00
Net Current Assets arrow
262.38 1,047.79 1,115.90 -301.50 198.03
Contingent Liabilities arrow
1.86 100.01 16.76 81.10 0.13

Cashflow (₹ Cr)

Thyrocare Tech Global Health Dr. Lal Pathlabs Krishna Institute Vijaya Diagno
Cash From Operating Activities arrow
213.24 714.39 635.61 510.80 270.59
Cash Flow from Investing Activities arrow
-23.01 -1,089.11 -421.86 -1,451.70 -174.22
Cash from Financing Activities arrow
-169.59 271.85 -263.57 940.30 -69.49
Net Cash Inflow / Outflow arrow
20.64 -102.87 -49.83 -0.60 26.88

Ratios

Profitability Ratios

 Thyrocare Tech Global Health Dr. Lal Pathlabs Krishna Institute Vijaya Diagno
ROCE (%) arrow
38.30 19.38 29.56 11.51 30.28
ROE (%) arrow
32.40 14.93 23.03 9.45 20.58
ROA (%) arrow
24.17 10.35 18.64 2.83 13.49
EBIT Margin (%) arrow
25.33 15.64 23.04 11.92 31.02
Net Margin (%) arrow
19.50 11.55 18.23 4.49 21.32
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Thyrocare Tech Global Health Dr. Lal Pathlabs Krishna Institute Vijaya Diagno
Revenue Growth (%) arrow
21.09 21.27 14.29 30.90 20.18
EBIT Growth (%) arrow
47.74 0.94 15.64 -16.88 26.22
Net Profit Growth (%) arrow
64.10 3.43 5.38 -52.81 24.27
EPS Growth (%) arrow
-13.18 2.70 -30.51 -42.60 23.44
Book Value Growth (%) arrow
6.70 16.51 15.41 5.13 21.86

Valuation Ratios

 Thyrocare Tech Global Health Dr. Lal Pathlabs Krishna Institute Vijaya Diagno
Price / Earnings arrow
29.42 60.76 45.63 131.38 80.20
Price / Book Value arrow
12.97 8.46 12.50 7.71 14.95
Dividend Yield (%) arrow
2.73 0.04 1.05 0.00 0.14
EV/EBITDA arrow
28.22 35.04 37.39 38.80 40.84
Market Cap (₹ Cr) arrow
5,567.00 25,841.07 22,015.15 24,901.98 8,864.05

Solvency Ratios

 Thyrocare Tech Global Health Dr. Lal Pathlabs Krishna Institute Vijaya Diagno
Debt to Equity arrow
0.00 0.15 0.00 1.19 0.00
Short term debt to equity ratio arrow
-- -- -- 0.15 --
Current Ratio arrow
3.39 2.67 3.48 0.76 2.60
Quick Ratio arrow
2.95 2.54 3.38 0.68 2.56
Interest Coverage arrow
68.91 8.83 30.37 2.08 7.84

Operating Efficiency Ratios

 Thyrocare Tech Global Health Dr. Lal Pathlabs Krishna Institute Vijaya Diagno
Debtors to sales (%) arrow
8.43 8.78 3.83 13.16 2.43
Asset Turnover arrow
1.22 0.88 0.99 0.62 0.62
Receivable days arrow
32.33 29.09 13.13 44.38 7.98
Inventory Days arrow
20.91 6.05 5.28 7.52 2.20
Payable days arrow
117.68 80.04 118.67 133.54 136.27
Cash Conversion Cycle arrow
-64.44 -44.90 -100.26 -81.64 -126.08
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...